PG
IMGN

PEAK6 Group’s Immunogen Inc IMGN Stock Holding History

PEAK6 Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,100
Closed -$28K – 5180
2015
Q4 		$28K Sell
2,100
-159,000
-99% -$1.96M ﹤0.01% 4438
2015
Q3 		$1.55M Buy
161,100
+138,400
+610% +$2.02M 0.01% 1782
2015
Q2 		$326K Sell
22,700
-600
-3% -$6.59K ﹤0.01% 3223
2015
Q1 		$209K Buy
+23,300
New +$169K ﹤0.01% 3407
2014
Q4 		– Sell
-22,100
Closed -$234K – 5241
2014
Q3 		$234K Buy
22,100
+1,200
+6% +$13.6K ﹤0.01% 3175
2014
Q2 		$248K Buy
20,900
+7,100
+51% +$89.1K ﹤0.01% 2997
2014
Q1 		$206K Buy
+13,800
New +$218K ﹤0.01% 3408

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

PEAK6 Group's IMGN Position: Q1 2016 in Review

PEAK6 Group sold out of Immunogen Inc (IMGN) in Q1 2016, closing a stake of 577 shares — an estimated $8K sold.

PEAK6 Group first reported a position in IMGN in Q1 2014 and held it in 5 quarters. The position peaked at $622K in Q2 2014. 143 funds tracked by Wall St. Rank hold IMGN as of Q1 2016.

  • PEAK6 Group reported no remaining Immunogen Inc position as of Q1 2016 after selling out during the quarter.
  • PEAK6 Group sold 577 Immunogen Inc shares in Q1 2016, an estimated $8K.
  • PEAK6 Group first reported a position in Immunogen Inc in Q1 2014 and held it in 5 quarters.
  • PEAK6 Group's Immunogen Inc position peaked at $622K in Q2 2014.
  • 143 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2016.

Based on PEAK6 Group's 13F filing for Q1 2016, filed 13 May 2016.